MSSP ACO Public Reporting

ACO Name and Location

Genovista Health, LLC
Previous Names: Genesis Physicians Group, Inc.
5501 LBJ Freeway
Suite 950
Dallas, TX 75240

ACO Primary Contact

Organizational Information

ACO ParticipantsACO Participant in Joint Venture
AB Internal Medicine Group PAN
Allen Children's Clinic, PA N
Aruna Koney, MD.,PAN
BRYAN G. JOHNSON MD, PAN
CHERRY CHANDI, M.D., P.A.N
CHIJIOKE D. UKOHA MD PAN
CHUKWUMA OSUAGWU MD PAN
CORINTHIA MCLEROY, MD PAN
Dennis Dinh Tran M.D.,PA.N
DOCTOR IS IN, PAN
Dr. Matthew Thompson PllcN
FAMILY CENTER VITALEHEALTH, PLLCN
FIROZ MEDICAL GROUP, PAN
FLESCHLER & PHILLIPS MEDICAL GROUP LLCN
Forest Lane Family Medicine, PAN
GENESIS HEALTH PARTNERS PLLCN
HIGHLAND VILLAGE PRIMARY CARE, P.A.N
IRVING COPPELL PRIMARY CARE DOCTORS PLLCN
Irwin S. Korngut MdpaN
JAMES E RACE MD PAN
Jocelyn B Dunham, MD, PAN
Kare Family ClinicN
KELSOM CLINIC PAN
Kenneth E. Baird, M.D., P.A.N
LIVINGSTON MEDICAL PLLCN
Love WoundsN
MAINMEDPLUS PLLCN
MELROSE CLINIC PLLCN
METROPLEX CARE GROUPN
North Texas Hospital Physicians GroupN
PREMIER FAMILY MEDICAL, PAN
PRUNA FAMILY MEDICINE PLLCN
QUESTCARE MEDICAL CLINICS PLLCN
RAKESH SAININ
Randall HayesN
RUFINO G. TALATALA, M.D., P.A.N
RUSHING FAMILY PRACTICEN
SINSOTE MEDICAL CARE PLLCN
SOPHIA RAHMAN MD PLLCN
VITAL CARE CLINIC, LLCN
YZ HEALTHCARE PAN

ACO Governing Body

Member Last NameMember First NameMember Title / PositionMember's Voting Power (Expressed as a % or #)Membership TypeACO Participant Legal Business Name / DBA (if applicable)
KorngutIrwinChairman Voting Member1ACO Participant RepresentativeIrwin S. Korngut Mdpa
BairdKennethVoting Member1ACO Participant RepresentativeKenneth E. Baird, M.D., P.A.
TalatalaRufinoVoting Member1ACO Participant RepresentativeRUFINO G. TALATALA, M.D., P.A.
DunhamJocelynVoting Member1ACO Participant RepresentativeJocelyn B Dunham, MD, PA
Del RosarioEdwinVoting Member1ACO Participant RepresentativeQUESTCARE MEDICAL CLINICS PLLC
ConoverSkylarVoting Member1Medicare Beneficiary RepresentativeNA

Associated Committees and Committee Leadership

Committee Name
Committee Leader Name and Position
Quality Improvement Committee
Anna Tseng MD, Chair
IT / Compliance Committee
Charles Dunlap MD, Chair
Membership Committee
Scott Yates MD, Chair
Finance Committee
John Tan MD, Chair

Key ACO Clinical and Administrative Leadership

  • James Walton
    ACO Executive
  • Anna Tseng
    Medical Director
  • Jessica Johnson
    Compliance Officer
  • Anna Tseng
    Quality Assurance / Improvement Officer
 
Types of ACO participants, or combinations of participants, that formed the ACO:
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses
  • First Agreement Period
    • Performance Year 2018, $1,705,464
    • Performance Year 2019, $1,195,336
    • Performance Year 2020, $4,182,206
Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 23%
      • Proportion invested in redesigned care processes/resources: 44%
      • Proportion of distribution to ACO participants: 33%
    • Performance Year 2019
      • Proportion invested in infrastructure: 23%
      • Proportion invested in redesigned care processes/resources: 44%
      • Proportion of distribution to ACO participants: 33%
    • Performance Year 2020
      • Proportion invested in infrastructure: 23%
      • Proportion invested in redesigned care processes/resources: 44%
      • Proportion of distribution to ACO participants: 33%

Quality Performance Results

2020 Quality Performance Results:
ACO#Measure NameRateACO Mean
ACO-43Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))1.190.95
ACO-13Falls: Screening for Future Fall Risk 88.7684.97
ACO-14Preventive Care and Screening: Influenza Immunization 55.6376.03
ACO-17Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention64.8681.67
ACO-18Preventive Care and Screening: Screening for Depression and Follow-up Plan51.7471.46
ACO-19Colorectal Cancer Screening71.9572.59
ACO-20Breast Cancer Screening66.4574.05
ACO-42Statin Therapy for the Prevention and Treatment of Cardiovascular Disease89.0483.37
ACO-27Diabetes: Hemoglobin A1c Poor Control (>9%) 9.7614.70
ACO-28Controlling High Blood Pressure 74.4572.87

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR §425.612.